ARDELYX, INC.
For the period ended Dec 31, 2025. Filed Feb 19, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 19, 2026
ARDX$2.93+1.7%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Statements of Stockholders’ Equity
(in thousands, except share amounts)
| Common Stock · Additional Paid-In Capital · Accumulated Deficit · Accumulated Other Comprehensive(Loss) Income · Total Stockholder’ Equity | ||||||
|---|---|---|---|---|---|---|
| Shares · Amount | ||||||
| Balance as of December 31, 2022 | 198,575,016 | $20 | $878,500 | $(780,137) | $(54) | $98,329 |
| Issuance of common stock under employee stock purchase plan | 435,708 | — | 808 | — | — | 808 |
| Issuance of common stock for services | 86,095 | — | 337 | — | — | 337 |
| Issuance of common stock upon exercise of options | 225,988 | — | 365 | — | — | 365 |
| Issuance of common stock upon vesting of restricted stock units | 855,642 | — | — | — | — | — |
| Issuance of common stock in at-the-market offering | 32,274,741 | 3 | 119,233 | — | — | 119,236 |
| Stock-based compensation | — | — | 13,530 | — | — | 13,530 |
| Unrealized gains on available-for-sale securities | — | — | — | — | 278 | 278 |
| Net loss | — | — | — | (66,067) | — | (66,067) |
| Balance as of December 31, 2023 | 232,453,190 | $23 | $1,012,773 | $(846,204) | $224 | $166,816 |
| Issuance of common stock under employee stock purchase plan | 479,609 | — | 2,227 | — | — | 2,227 |
| Issuance of common stock for services | 40,549 | — | 257 | — | — | 257 |
| Issuance of common stock upon exercise of options | 2,654,370 | 1 | 5,910 | — | — | 5,911 |
| Issuance of common stock upon vesting of restricted stock units | 2,388,107 | — | — | — | — | — |
| Stock-based compensation | — | — | 37,381 | — | — | 37,381 |
| Unrealized losses on available-for-sale securities | — | — | — | — | (167) | (167) |
| Net loss | — | — | — | (39,136) | — | (39,136) |
| Balance as of December 31, 2024 | 238,015,825 | $24 | $1,058,548 | $(885,340) | $57 | $173,289 |
| Issuance of common stock under employee stock purchase plan | 385,593 | — | 1,718 | — | — | 1,718 |
| Issuance of common stock for services | 87,256 | — | 315 | — | — | 315 |
| Issuance of common stock upon exercise of options | 1,880,472 | — | 4,123 | — | — | 4,123 |
| Issuance of common stock upon vesting of restricted stock units | 3,982,355 | — | — | — | — | — |
| Stock-based compensation | — | — | 48,962 | — | — | 48,962 |
| Unrealized gains on available-for-sale securities | — | — | — | — | 141 | 141 |
| Net loss | — | — | — | (61,599) | — | (61,599) |
| Balance as of December 31, 2025 | 244,351,501 | $24 | $1,113,666 | $(946,939) | $198 | $166,949 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.